Trial intelligence / Profile preview

Preoperative Radiochemotherapy With Hyperthermia for Rectal Cancer

NCT02353858Phase 2Completed

Sponsor
University Hospital Tübingen
Start
Aug 2012
Primary completion
Dec 2017
Countries
1
01

Overview

Phase 2, open-label, single-arm trial, sponsored by University Hospital Tübingen. Primary endpoint: Pathological Complete Response Rate. Started Aug 2012; status: completed.

Beyond the preview

Go deeper on NCT02353858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02353858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call